Cardiac Prosthetic Devices Market Size, Share, Growth – By Product, By End Use - Global Forecast, 2025 to 2034

Cardiac Prosthetic Devices Market Size

The global cardiac prosthetic devices market size was valued at USD 8.6 billion in 2024 and is expected to exhibit growth at a CAGR of 8.4% from 2025 to 2034. The high growth in the market can be propelled by factors such as advancements in technology applied in medical devices, the increase in the number of people suffering from cardiovascular disorders, the expansion in the number of the elderly, and the increase in the acceptance of minimally invasive procedures.
 

In addition, as the population ages, there is a high chance that such individuals will suffer from a heart problem and cardiac equipment is able to address the issue. For instance, a report from the United Nations (UN) estimates that around the world, the population of individuals aged 65 or older will increase threefold within the next 30 years. The older population is expected to reach 1.6 billion by 2050, which will account for more than 16 percent of the global population. Heart valve diseases occur more frequently in elderly patients, who might require interventions such as heart valve replacements and other cardiac prosthetic devices.
 

Additionally, the safety of cardiac prosthetic devices has improved tremendously as a result of the progress made in device designs and new implantation techniques that are less invasive. As an example, the refinements made to the transcatheter aortic valve replacement (TAVR) devices make them suitable for patients who are at high-risk for open-heart surgery.
 

Cardiac prosthetic devices are artificial devices which are either placed inside the patient’s heart or attached to the heart so as to substitute the original affected organs. Such devices are particularly used to restore the working of the heart when it has barely a chance of healing by the use of medication or if non-invasive therapies haven’t been successful.

Cardiac Prosthetic Devices Market Trends

The market is experiencing several market trends that are shaping its growth and development. These trends include rising acceptance of biological tri-leaflet heart valves, novel welding methods for constructing durable heart valves, increasing interest in hybrid prosthetic valves, among others.
 

• There is a growing demand for minimally invasive procedures, techniques such as transcatheter implantation of a heart valve and TAVI are less invasive than conventional open-heart surgery. The amount of time needed to recover decreases considerably, making it the best option for elderly or highly at-risk patients.
   
• Additionally, there is a trend of integrating cardiac prostheses with wearable heart monitoring devices. Furthermore, through patient pattern systems, cardiac prosthetic devices can send patients’ real-time data to their healthcare providers to monitor their device performance and heart conditions, allowing doctors to assist the patient when required. Thus, these factors are anticipated to contribute to the growth of the market.
   

Cardiac Prosthetic Devices Market Analysis

Based on product, the market is classified into pacemakers and heart valves. The pacemaker segment generated the highest revenue of USD 5.7 billion in 2024.
 

• The growing cases of conditions among them bradycardia, atrial fibrillation, and heart block, is a major driver for pacemakers. For instance, according to the American Heart Association reports in its 2021 update on Heart Disease and Stroke Statistics that Atrial Fibrillation currently affects nearly 5.2 million Americans, and this figure is expected to reach 12.1 million in 2030. These form other rhythm abnormalities of the heart which usually require the assistance of a pacemaker in order to control the rate of pulsations to avoid grave consequences.
   
• Moreover, continuous improvements in pacemaker technology have enhanced device functionality, durability, as well as safety. The introduction of the first leadless pacemaker, the first wireless MRI-conditional pacemaker, and other wireless technologies are broadening the horizon of treatment options while enhancing patients' comfort and outcomes and hence, market growth.

Based on end use, the cardiac prosthetic devices market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 9 billion by the end of the forecast period.
 

• Cardiac units are being built in hospitals, and this has created a demand for newer and more advanced cardiac prosthetic devices as these units are able to perform complicated surgery procedures and procedures using prosthetic devices to treat patients who are suffering from valve diseases or arrhythmias.
   
• Additionally, hospitals are focusing on the long-term cost-effectiveness of treatments. It follows that cardiac prosthetic devices which prevent patients from returning to the hospital as well as those that decrease recovery periods while enhancing a patient's chances of a positive outcome are worthwhile investments. For instance, low-invasive or even non-invasive valve replacement techniques and pacemakers that obviate the need for follow-up surgeries could assist hospitals in reducing costs whilst providing good patient care.

North America cardiac prosthetic devices market accounted for USD 3.7 billion market revenue in 2024 and is anticipated to grow at a CAGR of 7.7% between 2025 – 2034 period.
 

• The prevalence of coronary artery disease, heart failure, and arrhythmia is high in North America, especially in the US. Among the lifestyle factors, poor diet, sedentary lifestyle, obesity, and hypertension are the major contributors. The technology for pacemakers and heart valve prosthetic devices is also improving, and there is a growing need for these as the number of patients with diseases increases.
   
• The region is at the forefront of medical technology innovation, with continues new improvements being made in the design and function of these devices. Progress such as leadless pacemakers, MRI-safe pacemakers, and minimally invasive transcatheter heart valves (TAVR) has improved the treatment of heart disease considerably. These improvements in technology influence hospitals and other medical services to use these devices to enhance the quality of the services provided to patients.
   

Germany cardiac prosthetic devices market is projected to grow remarkably in the coming years.
 

• Germany has developed infrastructure with appropriate hospitals and cardiac centers, which can be of great help to the patients. Complex surgeries requiring the use of devices such as cardiac prosthetics can be performed at numerous leading healthcare facilities located in the nation. There is a good structure for implementing the use of these devices, and therefore, these devices are readily available and accessible to the patients.
   
• Government favor for reimbursing medical procedures that require the use of surgical devices, such as the implantation of pacemakers and the replacement of heart valves, encourages the general public to seek out such services and assists hospitals in implementing them. This is because they fall under the umbrella of the mandatory insurance scheme, which encompasses a wide range of medical services that even includes cardiac prosthetic devices.
   

China holds a dominant position in the Asia Pacific cardiac prosthetic devices market.
 

• China has a rapidly aging population due to increased life expectancy and the effects of the one-child policy. As the number of elderly people steadily increases, so does the prevalence of age-related cardiovascular illnesses. Furthermore, older adults are highly susceptible to developing such conditions as electrical disturbances in the heart, heart valve disease, and even more so to developing cardiovascular illnesses, which require the use of a variety of different cardiac prostheses such as pacemakers, heart valve replacements, etc. Hence, the aging population is a strong driver of the market.
   
• The nation has been actively making an effort to develop its healthcare framework and services. In urban areas, there is an increase in new and existing hospitals and specialized cardiac centers, which enable easy access to healthcare services for the majority of the population. Such improvements in the healthcare sector are accelerating the use of sophisticated technologies, including the use of cardiac prosthetic devices. Cardiac devices such as prosthetic devices are increasingly in demand, and there is a growing capacity at hospitals to undertake complex cardiac surgeries using these devices to meet the demand.
   

Cardiac Prosthetic Devices Market Share

The market is highly competitive, with both major and small players in the market. In these companies, more development work is being done in devices for minimally invasive techniques such as leadless pacemakers or transcatheter heart valves. There is stiff competition among the global and regional players, which enhances the market competition, and the rate of development and availability of new and affordable devices is growing rapidly.
 

Cardiac Prosthetic Devices Market Companies

Prominent players operating in the cardiac prosthetic devices industry include:

• Abbott Laboratories
• Abiomed
• AtriCure
• Biotronik
• Boston Scientific Corporation
• CryoLife
• Edwards Lifesciences Corporation
• Labcor Laboratórios
• Lepu Medical Technology
• Lifetech Scientific
• LivaNova
• Medtronic
• Meril Life Sciences
• MicroPort Scientific
• Siemens Healthcare
   

• Edwards Lifesciences has developed the SAPIEN series, which is a transcatheter aortic valve replacement (TAVR) device. These devices fall under their global dominance of TAV technology and are minimally invasive tools that allow a faster recovery for high-risk patients.
   
• Medtronic specializes in cardiac prosthetic devices along a wide-ranging spectrum, combining delivery systems. This guarantees accuracy in implantation procedures and, in turn, provides implantation patients with better results.
   
• CryoLife is the strongest player within the industry, specializing in surgical aortic valve replacement or repairs, while also actively working towards integrating innovative products into their existing portfolio.
   
• Boston Scientific Corporation is fortified with a strong global footprint, allowing it to sell its cardiac prosthetic devices worldwide in an efficient manner, strengthening its then-existing market position.
   

Cardiac Prosthetic Devices Industry News:

• In January 2022, Medtronic plc has announced that they had received the approval from Japan's Ministry of Health, Labor, and Welfare for the launch of Micra AV Transcatheter Pacing System (TPS) in Japan. This pacemaker is incorporated with advanced pacing technology and is intended for the treatment of AV block. This approval and product launch helped the company to expand their geographic presence and increase their customer base.
   
• In September 2021, Abbott Laboratories announced that they had received the U.S. Food and Drug Administration (FDA) approval for their Epic Plus and Epic Plus Supra Stented Tissue Valves for the diagnosis and treatment of aortic valve disease. These devices are equipped with advanced radiopaque markers to deliver long-term performance and durability and help improve the quality of life for patients. This regulatory approval helped the company to enhance their R and D capabilities and increase the customer base.
   

The cardiac prosthetic devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Pacemaker
  • Implantable pacemaker
  • External pacemakers
• Heart valves
  • Mechanical heart valve
  • Tissue heart valve
  • Transcatheter heart valve

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE